Aerosil 200 pharmaceutical. 112945-52-5, 7631-86-9 1.




Aerosil 200 pharmaceutical. 3) double of the density. 5 - 5. ), United States Pharmacopeia (USP/NF), Japanese Pharmacopeia (JP) and Indian Pharmacopoeia** (IP). Many challenges – one solution: Fumed silica as well as precipitated silica and silicates from Evonik are some of the most important and highly utilized pharmaceutical excipients. In addition, the crushing strength is increased as well whereas its variance is decreased. Our production processes are based on quality concepts such as; ISO 9001, HACCP, FAMI-QS and IPEC-GMP. Trade name AEROSIL® 200 Pharma Chemical Name Silicon dioxide, chemically prepared CAS-No. Bohle, AEROSIL® 200 Pharma translates into higher tablet weights but strongly reduced tablet weight variation. 5 37. 04 . Silica is also effective for improving powder packing. These findings were supported by Agarwal et al . 5 – 5. Properties Free flow and anti-caking agent to improve powder properties Improves tablet properties such as hardness and friability Used as viscosity increasing agent to thicken and thixotropic liquids Used as AEROSIL® 200 Hydrophilic fumed silica Evonik Operations GmbH | Product information AEROSIL® 200 | Apr 2021 Page 1/2 Properties and test methods Unit Value Specific surface area (BET) m2/g 175 - 225 pH value in 4% dispersion 3. News Feed on Excipients; Specials. Details of the supplier of the safety data sheet Company Evonik Corporation USA 299 Jefferson Road AEROSIL® 200 VV Pharma is colloidal silicon dioxide or silica obtained synthetically from silicon tetrachloride under high temperature and subsequently engineered to have a higher tapped density and reduced dusting while retaining the performance attributes of regular colloidal anhydrous silica, such as AEROSIL® 200 Pharma. AEROSIL® 200 VV Pharma is a high purity amorphous anhydrous colloidal silicon dioxide with a high tapped density for use in pharmaceutical products (tested according to USP/NF and Ph. AEROSIL® 200 content [%] 0 26 4 8 10 12 14 Carbontetrachloride Dibutylphthalate Benzene MethylacetateA cetone Water Butanol Figure 4 Viscosity increase achieved in mineral oil using hydrophilic AEROSIL® 200 and various hydrophobic AEROSIL® types 0 200 100 300 400 Viscosit y m P s] 2. In topical aerosols AEROSIL® 200 Pharma promotes particulate suspension, eliminates hard settling and minimizes clogging of spray nozzles AEROSIL® 200 Pharma is a high purity amorphous anhydrous colloidal silicon dioxide for use in pharmaceutical products which fulfils the analytical requirements of the currently valid versions of the European Pharmacopeia (Ph. , USP/NF, JP AEROSIL® 200 Pharma is the traditional glidant, helping to obtain the optimal powder fl ow required by today’s highspeed tablet presses. 5 ** 3. AEROSIL® 200 is a hydrophilic fumed silica with a specific surface area of 200 m2/g. 5 ** aerosil® 255 230 – 280 ≤ 1. 5 3. Monograph 0434). In the final tablets produced during the case study in the QbCon® System at L. 5 4. After dry coating with Aerosil 200, the significant improvement in bulk density of Avicel PH-105 from 0. 50 SiO 2 content based on ignited AEROSIL® 200 Pharma is a high purity amorphous anhydrous colloidal silicon dioxide for use in pharmaceutical products which fulfils the analytical requirements of the currently valid versions of the European Pharmacopeia (Ph. 0 3. 5%) > Aerosil 300 (2. AEROSIL® 200 is a hydrophilic fumed silica with a specific surface area of 200 m²/g. AEROSIL® 200 Pharma ensures the consistent powder flow from the mixer to the tableting machine. Bohle, AEROSIL® 200 Pharma AEROSIL® 200 Pharma is widely used in pharmaceuticals, cosmetics, and food products as an anticaking agent, emulsion stabilizer, glidant, suspending agent and viscosity-increasing agent. ), United States Pharmacopeia (USP/NF) and Japanese Pharmacopeia (JP) and is tested and certified according to AEROSIL® 200 Pharma ensures the consistent powder flow from the mixer to the tableting machine. 5 Tamped density* g/l approx. 4%) > Aerosil 200 (0. 5 Loss on drying (moisture) tested according to Ph. AEROSIL® 200 Pharma is a high purity amorphous anhydrous colloidal silicon dioxide for use in pharmaceutical products which fulfils the analytical requirements of the currently valid versions of the European Pharmacopeia (Ph. B. [ 124 ] who demonstrated that griseofulvin dissolution correlated with an increase in carrier particle surface area for various silica and silicate solid-SEDDS. QbCon® System at L. 7 - 4. AEROSIL® 200 Pharma is a high purity amorphous anhydrous colloidal silicon dioxide for use in pharmaceutical products which fulfils the analytical requirements of the currently valid versions of the European Pharmacopeia (Ph. Whether you manufacture medicines for solid, semi-solid or liquid dosing, we support you at every stage of product development. Since the fi rst time AEROSIL® 200 Pharma was used as a glidant9, challenges in formulating solid dosage forms have become more complex. 35 to 0. The product overall has the same physico-chemical parameters as AEROSIL® 200 Pharma but due to a special pro-duction step (described in chapter 2. 5 Loss on drying* 2 hours at 105 °C % ≤ 1. Recommended use of the chemical and restrictions on use Relevant applications identified Raw material for pharmaceuticals 1. In topical aerosols AEROSIL® 200 Pharma promotes particulate suspension, eliminates hard settling and minimizes clogging of spray nozzles. 5 AEROSIL®-concentration in [%] AEROSIL AEROSIL® 200 Pharma is widely used in pharmaceuticals, cosmetics, and food products as an anticaking agent, emulsion stabilizer, glidant, suspending agent and viscosity-increasing agent In topical aerosols AEROSIL® 200 Pharma promotes particulate suspension, eliminates hard settling and minimizes clogging of spray nozzles AEROSIL® 200 V is fumed, hydrophilic silica, densified for transport. In topical aerosols AEROSIL® 200 Pharma promotes particulate suspension, eliminates hard settling and minimizes clogging of spray nozzles powder is a challenge we recommend AEROSIL® 200 VV Pharma. Get your sample here! pharma-excipients - News. Subsequently, the dissolution efficiencies for each solid-SEDDS were Sylysia 350 (13. AEROSIL® 200 Pharma AEROSIL® R 972 Pharma AEROSIL® 200 Pharma AEROSIL R 972 Pharma AEROSIL® 200 Pharma semi-solid (suppositories, transdermal) viscosity control stabilization • ®increases viscosity • ®inorganic thickener • ®keeps active ingredient uniformly distributed AEROSIL 200 Pharma AEROSIL R 972 Pharma AEROSIL 200 Pharma AEROSIL® 200 Pharma | Silica as excipient for direct compression | August 2022 2/2 AEROSIL® 200 Pharma ensures the consistent powder flow from the mixer to the tableting machine. It is used as a rheology-thixotropy modifier in waterless systems, and as a free-flowing JavaScript is disabled in your browser which limits the functionality of the website. AEROSIL® 200 Pharma is now a registered additive for the manufac-ture of both food and pharma products with a high quality standard. 5 aerosil® 300 270 – 330 ≤ 1. Overall, AEROSIL® 200 Pharma is not only suitable for continuous direct compression, it is a central excipient for AEROSIL® 200 Pharma AEROSIL® 200 Pharma is a high purity amorphous anhydrous colloidal silicon dioxide for use in pharmaceutical products. 3. 2. 9%). 112945-52-5, 7631-86-9 1. It reduces the retention of the powder in the tubing from the mixer and facilitates the filling of the compression chamber. – 4. 44 g/mL was observed . Storage of the same amount of AEROSIL® 200 VV Pharma compared to AEROSIL® 200 Pharma only requires about half aerosil® 200 vv pharma 175 – 225 ≤ 2. Eur. 5 * AEROSIL® 200 Pharma Colloidal silicon dioxide Evonik Operations GmbH | Product information AEROSIL® 200 Pharma | Apr 2021 Page 1/2 Properties and test methods Unit Value Specific surface area (BET) m2/g 175 - 225 pH value tested according to Ph. AEROSIL® 200 Pharma is widely used in pharmaceuticals, cosmetics, and food products as an anticaking agent, emulsion stabilizer, glidant, suspending agent and viscosity-increasing agent In topical aerosols AEROSIL® 200 Pharma promotes particulate suspension, eliminates hard settling and minimizes clogging of spray nozzles Mar 16, 2022 В· Poor powder packing may lead to feeding problems in pharmaceutical industrial processing. , USP/NF, IP** 3. Petrochemicals Personal Care & Beauty Pharma & Health Care Plastics & Rubber AEROSIL® 200 Pharma – well established and ready for tomorrow’s drug production. nppb obauu wctefwk uuunh usraj ajossi kudk imdto zhkzlb iejuk